“…Additionally, the occurrence of EF after chemotherapy, bone marrow transplantation (BMT), or stem cell transplantation (SCT) is a commonly reported feature 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15Table IIClinicopathologic features of EF associated with underlying hematologic malignancy other than CLLStudy | Age, y | Sex | Underlying hematologic malignancy | Treatment for malignancy | Peripheral eosinophilia | Clinical description | Distribution | Notable histologic features |
Takamura et al 6 | 77 | M | Mantle cell lymphoma | Chemotherapy | 13% | Pruritic, erythematous papules | Face, neck | Eosinophils around follicles and sebaceous glands |
Takamura et al 6 | 60 | M | Mantle cell lymphoma | Chemotherapy | 3.7% | Pruritic, follicular reddish papules | Face | Eosinophils around follicles and sebaceous glands |
Bhandare et al 8 | 64 | F | Splenic marginal zone lymphoma | Chemotherapy | 2968/mL 3 | Pruritic, follicular papules and pustules | Scalp, back, proximal extremities | Follicular spongiosis with eosinophils |
Zitelli et al 1 | 56 | M | Acute lymphoblastic leukemia | Autologous SCT | 6.4% | Pruritic papules and pustules | Face, chest, and back | Intrafollicular collections of eosinophils |
Sugaya et al 9 | 42 | M | Sézary syndrome | N/A | 9.5% | Pruritic reddish follicular papules | Cheeks | Prominent follicular exocytosis of eosinophils |
Rashid et al 10 | 74 | M | Chronic myelomonocytic leukemia | Chemotherapy | N/A | Pruritic perifollicular papules | Neck and chest | Perifollicular infiltrates with eosinophils, follicular mucin |
Goiriz et al 7 | 25 | F | Acute eosinophilic leukemia | Allogene... |
…”